JP2017517255A - 微粉化ホウォートンゼリー - Google Patents

微粉化ホウォートンゼリー Download PDF

Info

Publication number
JP2017517255A
JP2017517255A JP2016568573A JP2016568573A JP2017517255A JP 2017517255 A JP2017517255 A JP 2017517255A JP 2016568573 A JP2016568573 A JP 2016568573A JP 2016568573 A JP2016568573 A JP 2016568573A JP 2017517255 A JP2017517255 A JP 2017517255A
Authority
JP
Japan
Prior art keywords
micronized
jelly
composition
whaton
particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016568573A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017517255A5 (enExample
Inventor
スペンサー，ランドール
シス，ソマリー
Original Assignee
ミメディクス グループ インコーポレイテッド
ミメディクス グループ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ミメディクス グループ インコーポレイテッド, ミメディクス グループ インコーポレイテッド filed Critical ミメディクス グループ インコーポレイテッド
Publication of JP2017517255A publication Critical patent/JP2017517255A/ja
Publication of JP2017517255A5 publication Critical patent/JP2017517255A5/ja
Priority to JP2020096350A priority Critical patent/JP7304316B2/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/51—Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10—Mechanical dissociation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2016568573A 2014-05-21 2015-05-21 微粉化ホウォートンゼリー Pending JP2017517255A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020096350A JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462001600P 2014-05-21 2014-05-21
US62/001,600 2014-05-21
PCT/US2015/032078 WO2015179711A1 (en) 2014-05-21 2015-05-21 Micronized wharton's jelly

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2020096350A Division JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Publications (2)

Publication Number Publication Date
JP2017517255A true JP2017517255A (ja) 2017-06-29
JP2017517255A5 JP2017517255A5 (enExample) 2018-06-14

Family

ID=54554801

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016568573A Pending JP2017517255A (ja) 2014-05-21 2015-05-21 微粉化ホウォートンゼリー
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2020096350A Active JP7304316B2 (ja) 2014-05-21 2020-06-02 微粉化ホウォートンゼリー

Country Status (5)

Country Link
US (1) US20150335686A1 (enExample)
EP (1) EP3146039A4 (enExample)
JP (2) JP2017517255A (enExample)
AU (2) AU2015264025A1 (enExample)
WO (1) WO2015179711A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022543362A (ja) * 2019-08-08 2022-10-12 ティシュー リジェネレイション セラピューティックス、インコーポレイテッド 血管周囲溶解物及びその使用

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2623940C (en) 2005-09-27 2017-01-10 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
US9526770B2 (en) 2011-04-28 2016-12-27 Tissuetech, Inc. Methods of modulating bone remodeling
CA2837878A1 (en) 2011-06-10 2012-12-13 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
EP3167049A4 (en) * 2014-07-08 2017-11-29 MIMEDX Group Inc. Micronized wharton's jelly
US10201573B1 (en) * 2014-10-27 2019-02-12 Brahm Holdings, Llc Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
JP2018516869A (ja) 2015-05-20 2018-06-28 ティッシュテック，インク． 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法
US10420802B2 (en) 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
CA3050082A1 (en) 2016-04-04 2017-10-12 Omeza LLC Fish oil topical composition
EP3474869B1 (en) * 2016-06-24 2025-04-09 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
FR3070262B1 (fr) 2017-08-23 2020-10-16 Tbf Genie Tissulaire Tbf Composition comprenant de la gelee de wharton, procede de preparation et utilisations
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
CA3076485A1 (en) * 2017-09-19 2019-03-28 Gary M. Petrucci Amnion tissue preparations and methods of using
CA3075106A1 (en) * 2017-10-19 2019-04-25 Lifecell Corporation Flowable acellular tissue matrix products and methods of production
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
US20230047934A1 (en) * 2020-03-12 2023-02-16 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
WO2022159789A1 (en) * 2021-01-25 2022-07-28 Biostem Technologies, Inc. Two-part clotting composition and methods of making and using thereof
WO2023205236A1 (en) * 2022-04-20 2023-10-26 Biostem Technologies, Inc. Multi-part processed human amniotic composition and methods of making and using thereof for treatment of peyronie's disease
CA3263067A1 (en) * 2022-07-26 2024-02-01 Biostem Tech Inc COMPOSITIONS BASED ON HUMAN UMBILICAL CORD AND INTRA-ARTICULAR THERAPY METHODS
US20240226181A1 (en) * 2023-01-11 2024-07-11 Biostem Technologies, Inc. Human umbilical cord composition for treatment of peyronie's disease

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080069895A1 (en) * 2006-08-15 2008-03-20 Qing Liu Umbilical cord biomaterial for medical use
US20080181967A1 (en) * 2006-10-04 2008-07-31 Qing Liu Placental or umbilical cord tissue compositions
CN102198292A (zh) * 2010-03-26 2011-09-28 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
JP2012505188A (ja) * 2008-10-10 2012-03-01 イストセル，エセ．エレ． ヒト臍帯のウォートン・ジェリー由来の新規な生物材料
JP2013523227A (ja) * 2010-03-30 2013-06-17 イストセル，エセ．エレ． ウォートンジェリー臍帯由来の新規の生体材料
US20140050788A1 (en) * 2012-08-15 2014-02-20 Mimedx Group Inc. Micronized placental tissue compositions and methods of making and using the same
JP2014505111A (ja) * 2011-02-14 2014-02-27 ミメドックス グループ インコーポレーティッド 微粉化胎盤組織の組成物ならびにそれを作成および使用する方法
WO2014058804A2 (en) * 2012-10-08 2014-04-17 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) * 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
US9005646B2 (en) * 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
AU2012217975B2 (en) * 2011-02-14 2015-11-19 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
ES2890126T3 (es) * 2011-12-30 2022-01-17 Amit Patel Métodos y composiciones para la obtención clínica de una célula alogénica y usos terapéuticos
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
WO2014028657A1 (en) * 2012-08-15 2014-02-20 Mimedx Group, Inc Reinforced placental tissue grafts and methods of making and using the same
WO2015038477A1 (en) * 2013-09-10 2015-03-19 Mimedx Group, Inc. Cosmetic uses of molded placental compositions

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080069895A1 (en) * 2006-08-15 2008-03-20 Qing Liu Umbilical cord biomaterial for medical use
US20080181967A1 (en) * 2006-10-04 2008-07-31 Qing Liu Placental or umbilical cord tissue compositions
JP2012505188A (ja) * 2008-10-10 2012-03-01 イストセル，エセ．エレ． ヒト臍帯のウォートン・ジェリー由来の新規な生物材料
CN102198292A (zh) * 2010-03-26 2011-09-28 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
JP2013523227A (ja) * 2010-03-30 2013-06-17 イストセル，エセ．エレ． ウォートンジェリー臍帯由来の新規の生体材料
JP2014505111A (ja) * 2011-02-14 2014-02-27 ミメドックス グループ インコーポレーティッド 微粉化胎盤組織の組成物ならびにそれを作成および使用する方法
US20140050788A1 (en) * 2012-08-15 2014-02-20 Mimedx Group Inc. Micronized placental tissue compositions and methods of making and using the same
WO2014058804A2 (en) * 2012-10-08 2014-04-17 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022543362A (ja) * 2019-08-08 2022-10-12 ティシュー リジェネレイション セラピューティックス、インコーポレイテッド 血管周囲溶解物及びその使用

Also Published As

Publication number Publication date
EP3146039A1 (en) 2017-03-29
EP3146039A4 (en) 2017-11-29
WO2015179711A1 (en) 2015-11-26
AU2015264025A1 (en) 2016-12-01
JP2020143150A (ja) 2020-09-10
AU2021211985A1 (en) 2021-08-26
JP7304316B2 (ja) 2023-07-06
US20150335686A1 (en) 2015-11-26
AU2021211985B2 (en) 2023-06-01

Similar Documents

Publication Publication Date Title
JP7304316B2 (ja) 微粉化ホウォートンゼリー
US10307443B2 (en) Micronized wharton's jelly
AU2022200614B2 (en) Micronized placental tissue compositions and methods of making and using the same
JP7749620B2 (ja) コラーゲンおよび微粉化胎盤組織からなる組成物ならびにその調製および使用方法
KR102331661B1 (ko) 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법
EP3191145B1 (en) Micronized placental tissue compositions
US20140255496A1 (en) Micronized placental tissue compositions and methods of making and using the same
JP2016529070A (ja) 成形胎盤組成物の美容的使用
JP6756612B2 (ja) キレーターを含む微粒子化した胎盤性組成物
KR102903446B1 (ko) 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180501

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180501

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190322

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190402

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190701

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190830

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20190830

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20200204

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200602

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20200602

C11 Written invitation by the commissioner to file amendments

Free format text: JAPANESE INTERMEDIATE CODE: C11

Effective date: 20200616

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20200804

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20200811

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20201009

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20201013

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210323

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20210420

C23 Notice of termination of proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C23

Effective date: 20210427

C03 Trial/appeal decision taken

Free format text: JAPANESE INTERMEDIATE CODE: C03

Effective date: 20210601

C30A Notification sent

Free format text: JAPANESE INTERMEDIATE CODE: C3012

Effective date: 20210601